Table 2.
Clinical applications and significance of dd-cfDNA in liver transplantation
| Clinical Application | Changes in dd-cfDNA Levels | Significance | Reference |
|---|---|---|---|
| Early Diagnosis of AR | Early in acute rejection, dd-cfDNA shows a significant increase, usually higher than the normal range | Can serve as an early warning signal for acute rejection, providing higher sensitivity and earlier diagnostic capability compared to traditional liver biopsy | [5] |
| Monitoring of Graft Function | Positively correlated with the recovery or deterioration of liver function, particularly with the levels of ALT and AST | Can be used to monitor liver damage or functional recovery in real time, overcoming the limitations of traditional biochemical tests and biopsies | [3] |
| Prediction of IRI | Rise rapidly and are correlated with the severity of the damage | Predict the occurrence of IRI and its impact on liver function, offering an opportunity for early intervention | [51] |
| Infection Monitoring and Complication Diagnosis | In cases of infection or other complications, dd-cfDNA levels often increase significantly | Help identify bacterial or viral infections after transplantation | [52] |
| Long-term Monitoring and Prognostic Assessment | Are associated with chronic rejection and chronic graft dysfunction | Not only for short-term monitoring, but also for the prediction of long-term post-transplant rejection and chronic liver failure | [11] |
Abbreviations AR Acute rejection, IRI Ischemia–reperfusion injury, ALT Alanine Aminotransferase, AST Aspartate Aminotransferase